Patents by Inventor Mark A. Sanner

Mark A. Sanner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5883094
    Abstract: This invention relates to novel, pharmaceutically active benzimidazolone derivatives of the formula ##STR1## wherein the dashed line, R.sup.0 through R.sup.6 and X.sup.1 through X.sup.3 are defined as in the specification. These compounds exhibit central dopaminergic activity and are u in the treatment of CNS disorders.
    Type: Grant
    Filed: March 11, 1997
    Date of Patent: March 16, 1999
    Assignee: Pfizer Inc.
    Inventors: Anton F-J. Fliri, Brian T. O'Neill, William S. Faraci, Mark A. Sanner, Stevin H. Zorn
  • Patent number: 5852031
    Abstract: Substituted pydrido?1,2-a!pyrazines of general formula I wherein Ar and Ar.sup.1 represent various carbocyclic and heterocyclic aromatic rings; A represents O, S, SO, SO.sub.2, C.dbd.O, CHOH, or --(CR.sup.3 R.sup.4) and n is 0-2 as well as precursors thereto are ligands for dopamine receptor subtypes within the body and are therefore useful in the treatment of disorders of the dopamine system.
    Type: Grant
    Filed: March 26, 1997
    Date of Patent: December 22, 1998
    Assignee: Pfizer Inc.
    Inventors: Kishor A. Desai, Anton F. J. Fliri, Mark A. Sanner
  • Patent number: 5714487
    Abstract: This invention relates to compounds of formula I ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, X, m and n are defined as in the specification, their pharmaceutically acceptable salts and pharmaceutical compositions containing such compounds or their salts.
    Type: Grant
    Filed: December 23, 1996
    Date of Patent: February 3, 1998
    Assignee: Pfizer Inc.
    Inventor: Mark A. Sanner